IMM 4.92% 32.0¢ immutep limited

Ann: Good safety reported from 1st five patients in INSIGHT-003, page-15

  1. 601 Posts.
    lightbulb Created with Sketch. 839
    Gd'evening Ahjay
    No presumption or assumption on my part
    Pure speculation
    And that's what we do on these types of forums isn't it - speculate/pontificate/theorise/hypothesise

    It all matters not really to IMM outcomes but this is a forum for all above and add a pinch of frustration and venting.

    For me - Immutep has not yet added $$ value for its shareholders by increase share price (market cap is woeful) for a 'late stage' biotech despite clinical successes.

    Maybe there is more value for BP elsewhere amongst 1500 trials ongoing.
    Is that what you are assuming Ahjay?
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.015(4.92%)
Mkt cap ! $464.8M
Open High Low Value Volume
30.0¢ 32.5¢ 30.0¢ $1.168M 3.702M

Buyers (Bids)

No. Vol. Price($)
5 148547 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 51809 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.